School of Medicine

Photo by Robert BostonMissouri Gov. Matt Blunt signed Senate Bill 567, which requires health insurers to cover primary health-care costs for patients involved in approved phase II clinical trials for cancer.

Heavy metal Robert L. Barrack, M.D., (right) performs a hip implant with the Birmingham Hip on a patient at Barnes-Jewish Hospital. Barrack was the first U.S. surgeon to implant the system, which resurfaces the head of the femur with a metal hip joint and leaves the patient’s thighbone intact.

A test developed at the School of Medicine may help diagnose Alzheimer’s disease prior to the onset of clinical symptoms.

A School of Medicine study showed that germ-free mice that received two prominent human gut microbes got fatter.

J. William Harbour, M.D., a specialist in diagnosing and treating eye tumors, was named the Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences.

School of Medicine researchers will study whether putting a normal-weight person on calorie restriction will change markers of aging,

The new Diabetes Center at the Center for Advanced Medicine will provide a new group-care and patient-education approach.

WellingThe Washington University Diabetes Center at Barnes-Jewish Hospital focuses on providing patients with the latest technology, treatments and clinical research. Some patients at the center are receiving a new diabetes drug that may give a welcome side effect — weight loss. Research lab supervisor Cris Welling began taking Byetta about 10 months ago and has lost 40 pounds.

Like the fictional wizard Harry Potter, some cancerous tumors seem capable of wrapping themselves in an invisibility cloak. Researchers at the School of Medicine have found that pancreatic tumors hide from the body’s immune surveillance by surrounding themselves with cells that make it hard for the immune system to detect them.

TobinPatients managing diabetes can now get full diagnostics, treatment and education in one place — the Washington University Diabetes Center at Barnes-Jewish Hospital. The center will provide a new group-care and patient-education approach for patients with type 1 or type 2 diabetes, says Garry Tobin, medical director of the center.